The role of anorexia nervosa in secondary osteoporosis development with the risk for low energy fractures

Endokrynologia Polska

Volumn 62, Issue 1, 2011, Pages 45-47

  Horst Sikorska, Wanda ^a   Ignaszak Szczepaniak, Magdalena ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Anorexia nervosa; Risk of fracture; Secondary osteoporosis

Indexed keywords

ALENDRONIC ACID; ENDOCANNABINOID; ESTROGEN; GHRELIN; LEPTIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANOREXIA NERVOSA; BONE DENSITY; BONE MASS; BONE MINERAL; BONE STRUCTURE; CAUSE OF DEATH; ESTROGEN DEFICIENCY; FRACTURE; HUMAN; NUTRITIONAL DISORDER; OSTEOPOROSIS; PROGNOSIS; REVIEW; RISK FACTOR; SECONDARY OSTEOPOROSIS; WEIGHT REDUCTION;

EID: 79953809713     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Owed R, Hotter M, Sato K et al. The relationship between serum levels of estuarial and osteoprotegerin in patients with anorexia nervosa. Endocr J 2007; 54: 953-959. (Pubitemid 351346779)
2. Giustoma A., Mazziotti G, Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 2008; 29: 535-559.
3. Misra M, Klibanski A. Anorexia nervosa and osteoporosis. Rev Endocr Metab Disord 2006; 7: 91-99. (Pubitemid 46044351)
4. Hotta M, Fakuda I, Sato K et al. The relationship between turnover and body weight, serum insulin - like growth factor (IGF) I, and serum IGF - binding protein levels in patiens with anorexia nervosa. J Clin Endocrinol Metab 2000; 85: 200-206.
5. Rigotti NA, Neer RM, Skates SJ et al. The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA1991; 265: 1133-1138.
6. Meczekalski B, Podfigurna A, Genazzani AR. Hypoestrogenism in young women and its influence on bone mass. Gynecol Endocrinol 2010; 26: 652-657.
7. Ostrowska Z, Ziora K, Kos-Kudła B et al. Melatonin, the RANKL/RANK/OPG system, and bone metabolism in girls with anorexia nervosa. Endokrynol Pol. 2010; 61: 117-23.
8. Gowin E, Ignaszak-Szczepaniak M, Horst-Sikorska W. Niedożywione grubasy. Farmacja współczesna 2010; 3: 15-19.
9. Calero JA, Muńoz MT, Argente J et al A variation in Bone Alkaline Phosphatase levels that correlates positively with bone loss and normal levels of aminoterminal propeptide of collagen I in girls with anorexia nervosa. Clin Chim Acta 1999; 285: 121-129. (Pubitemid 29347176)
10. Misra M, Katzman DK, Cord J et al. Bone metabolism in adolescent boys with anorexia nervosa. J Clin Endocrinol Metab 2008; 93: 3029-3036.
11. Hergenroeder AC. Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults. J Pediatr 1995; 126: 683-689.
12. Trombett A, Richedrt L, Rizzoli R. Anorexia nervosa and its consequences on bone: a therapeutic challange. Rev Med. Suisse 2007; 3: 1502-1505. (Pubitemid 47024587)
13. Golden NH, Lanzkowsky L, Schebendach J et al. The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol 2002; 15: 135-143. (Pubitemid 34832457)
14. Golden NH, Iglesias EA, Jacobson MS et al. Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2005; 90: 3179-3185. (Pubitemid 41014272)
15. Mehler PS, MacKenzie TD. Treatment of osteopenia and osteoporosis in anorexia nervosa: a systematic review of the literature. Int J Eat Disord 2009; 42: 195-201.